How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like Idera Pharma Announces Appointment Of As Senior Vice President Of Early Development February 5, 2017 Navidea Completes Sale Of North American Rights Of Lymphoseek To Cardinal Health March 5, 2017 Meet the 5 Scientists Who Just Won Silicon Valley Billionaires' Breakthrough Prize December 4, 2017
